SCHEMBL14434657

SCHEMBL14434657

CCCCCCN1C(=O)c2cccc3c(NCCCCCCO)ccc(c23)C1=O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.77
HTT P42858 5/20 0.77
MEN1 O00255 5/20 0.77
MAPT P10636 3/20 0.77
RGS12 O14924 2/20 0.77
USP2 O75604 2/20 0.77
POLB P06746 2/20 0.77
MAPK1 P28482 1/20 0.77
ATM Q13315 1/20 0.77
NPSR1 Q6W5P4 1/20 0.77
TLR9 Q9NR96 1/20 0.77
TDP1 Q9NUW8 1/20 0.77
L3MBTL1 Q9Y468 1/20 0.77
DYRK3 O43781 1/20 0.74
RPS6KB1 P23443 1/20 0.74
EPHA2 P29317 1/20 0.74
FLT4 P35916 1/20 0.74
CSNK2A1 P68400 1/20 0.74
FGFR1 P11362 2/20 0.68
KDR P35968 2/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1505234 0.94 MEN1 (0.70) KMT2AHTTMEN1MAPTRGS12
SCHEMBL7799818 0.94 KMT2A (0.86) KMT2AHTTMEN1MAPTRGS12
SCHEMBL8397978 0.94 KMT2A (0.86) KMT2AHTTMEN1MAPTRGS12
SCHEMBL1505144 0.94 MEN1 (0.70) KMT2AHTTMEN1MAPTRGS12
SCHEMBL8396375 0.94 KMT2A (0.86) KMT2AHTTMEN1MAPTRGS12
SCHEMBL1505179 0.93 KMT2A (0.88) KMT2AHTTMEN1MAPTRGS12
SCHEMBL19718354 0.92 KMT2A (0.86) KMT2AHTTMEN1MAPTRGS12
SCHEMBL1580657 0.89 KMT2A (0.84) KMT2AHTTMEN1MAPTRGS12
SCHEMBL17228671 0.88 FGFR1 (0.83) KMT2AHTTMEN1MAPTRGS12
SCHEMBL1505152 0.87 MEN1 (0.73) KMT2AHTTMEN1MAPTRGS12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070189987-A1 Composition comprising a monomeric compound with an optical effect, process using said composition, monomeric compound, polymer comprising the same and use thereof LUUKAS TIMO 2007-08-16 US disclosed
US-20070189987-A1 Composition comprising a monomeric compound with an optical effect, process using said composition, monomeric compound, polymer comprising the same and use thereof LUUKAS TIMO 2007-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070189987-A1 Composition comprising a monomeric compound with an optical effect, process using said composition, monomeric compound, polymer comprising the same and use thereof KRT18, MITF, CUTA KMT2A 2195/4885HTT 809/4885MEN1 57/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.